WO2010047829A1 - Mutant hepatitis c virus e2 polypeptides for hcv treatment - Google Patents

Mutant hepatitis c virus e2 polypeptides for hcv treatment Download PDF

Info

Publication number
WO2010047829A1
WO2010047829A1 PCT/US2009/005785 US2009005785W WO2010047829A1 WO 2010047829 A1 WO2010047829 A1 WO 2010047829A1 US 2009005785 W US2009005785 W US 2009005785W WO 2010047829 A1 WO2010047829 A1 WO 2010047829A1
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
mutant
antibody
e2 polypeptide
virus
Prior art date
Application number
PCT/US2009/005785
Other languages
French (fr)
Inventor
Mansun Law
Dennis R. Burton
Original Assignee
The Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US19727308P priority Critical
Priority to US61/197,273 priority
Application filed by The Scripps Research Institute filed Critical The Scripps Research Institute
Publication of WO2010047829A1 publication Critical patent/WO2010047829A1/en

Links